News Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston Staff September 11, 2023 Iframe sync Post navigation Previous: Major shareholder announcement – BlackRock, Inc.Next: Quipt Announces Multi-State Acquisition Adding Approximately $9 Million in Annualized Revenues, and Anticipated $2 Million in Adjusted EBITDA Post Integration More Stories Diagnostics Healthcare News Pharmaceutical Babson Diagnostics Wins Best Abstract Award at 2025 EFLM Preanalytical Conference Staff December 18, 2025 Healthcare News New Obesity Medicine Association Initiative Aims to Scale High-Impact Obesity Healthcare Improvements Nationwide Staff December 18, 2025 News Attune’s to Support Poppy Health’s $38M ARPA-H BREATHE Project in the U.S. Schools Staff December 18, 2025
